UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | K | L | M | N | O | P | Q | R | S | T | V | W | Z
Number of items: 227.

A

Ahmed, N; Salsman, VS; Yvon, E; Louis, CU; Perlaky, L; Wels, WS; Dishop, MK; ... Gottschalk, S; + view all (2009) Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression. MOLECULAR THERAPY , 17 (10) pp. 1779-1787. 10.1038/mt.2009.133.

Altvater, B; Landmeier, S; Pscherer, S; Temme, J; Schweer, K; Kailayangiri, S; Campana, D; ... Rossig, C; + view all (2009) 2B4 (CD244) Signaling by Recombinant Antigen-specific Chimeric Receptors Costimulates Natural Killer Cell Activation to Leukemia and Neuroblastoma Cells. CLINICAL CANCER RESEARCH , 15 (15) pp. 4857-4866. 10.1158/1078-0432.CCR-08-2810.

Arce, F; Rowe, HM; Chain, B; Lopes, L; Collins, MK; (2009) Lentiviral Vectors Transduce Proliferating Dendritic Cell Precursors Leading to Persistent Antigen Presentation and Immunization. MOL THER , 17 (9) 1643 - 1650. 10.1038/mt.2009.149.

Arce, F; Rowe, HM; Chain, B; Lopes, L; Collins, MK; (2009) Lentiviral vectors transduce proliferating dendritic cell precursors leading to persistent antigen presentation and immunization. Molecular Therapy , 17 (9) pp. 1643-1650. 10.1038/mt.2009.149.

B

Banerjee, L; Mansour, M; Khwaja, A; (2009) Combined blockade of PI3-kinase and mTOR synergizes with gamma-secretase inhibitors to induce a high level of cell death in T-cell acute lymphoblastic leukaemia cells with activated Notch signalling. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 9 - 10). WILEY-BLACKWELL PUBLISHING, INC

Baou, M; Jewell, A; Muthurania, A; Wickremasinghe, RG; Yong, KL; Carr, R; Marsh, P; (2009) Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells. LEUKEMIA , 23 (5) 986 - 989. 10.1038/leu.2008.340.

Barrowcliffe, TW; Chandler, WL; Favaloro, EJ; Gardiner, C; Goodeve, A; Gray, E; Jennings, I; ... others, ; + view all (2009) Dorothy M. Adcock MD. In: UNSPECIFIED John Wiley & Sons

Baxter-Lowe, LA; Maiers, M; Spellman, SR; Haagenson, MD; Wang, T; Fernandez-Vina, M; Marsh, SGE; ... Hurley, CK; + view all (2009) HLA-A Disparities Illustrate Challenges for Ranking the Impact of HLA Mismatches on Bone Marrow Transplant Outcomes in the United States. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , 15 (8) pp. 971-981. 10.1016/j.bbmt.2009.04.015.

Baxter-Lowe, LA; Maiers, M; Spellman, SR; Haagenson, MD; Wang, T; Fernandez-Vina, M; Marsh, SGE; ... Hurley, CK; + view all (2009) HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States. pp. 971-981.

Bergamini, G; Cigana, C; Sorio, C; Della Peruta, M; Pompella, A; Corti, A; Huaux, FA; ... Melotti, P; + view all (2009) Effects of Azithromycin on Glutathione S-Transferases in Cystic Fibrosis Airway Cells. AM J RESP CELL MOL , 41 (2) 199 - 206. 10.1165/rcmb.2008-0013OC.

Berro, M; Mayor, NP; Cooke, L; Kusminsky, G; Marsh, SGE; Madrigal, JA; Shaw, BE; (2009) TGFB1 codon 10 polymorphism: Impact on outcome in allogeneic unrelated donor hematopoietic stem cell transplantation. In: TISSUE ANTIGENS. (pp. 488 - 488). WILEY-BLACKWELL PUBLISHING, INC

Billottet, C; Banerjee, L; Vanhaesebroeck, B; Khwaja, A; (2009) Inhibition of Class I Phosphoinositide 3-Kinase Activity Impairs Proliferation and Triggers Apoptosis in Acute Promyelocytic Leukemia without Affecting Atra-Induced Differentiation. CANCER RES , 69 (3) 1027 - 1036. 10.1158/0008-5472.CAN-08-2608.

Boffa, MC; Cohen, H; Tincani, A; (2009) Diagnostic criteria for the obstetric antiphospholipid syndrome. In: (Proceedings) VII European Forum on antiphospholipid antibodies.

Bowen, D; Groves, MJ; Burnett, AK; Patel, Y; Allen, C; Green, C; Gale, RE; ... Med Res Council Adult Leukaemia Wo, ; + view all (2009) TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis. LEUKEMIA , 23 (1) 203 - 206. 10.1038/leu.2008.173.

Brewin, J; Mancao, C; Straathof, K; Karlsson, H; Samarasinghe, S; Amrolia, PJ; Pule, M; (2009) Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease. Blood , 114 (23) pp. 4792-4803. 10.1182/blood-2009-07-228387.

Brewin, J; Mancao, C; Straathof, K; Karlsson, H; Samarasinghe, S; Amrolia, PJ; Pule, M; (2009) Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease. BLOOD , 114 (23) pp. 4792-4803. 10.1182/blood-2009-07-228387.

Brewin, J; Straathof, K; Karlsson, H; Mancao, C; Samarasinghe, S; Savoldo, B; Dotti, G; ... Amrolia, P; + view all (2009) Generation of EBV CTL resistant to calcineurin inhibitors for treatment of post transplant lymphoproliferative disease. In: (Proceedings) 35th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation. (pp. S74-S74). NATURE PUBLISHING GROUP

Brown, NW; Hiwarkar, P; Shaw, BE; Kulkarni, S; Saso, R; Evans, S; Treleaven, J; ... Tredger, JM; + view all (2009) Mycophenolic Acid Concentration Monitoring for Mycophenolate Mofetil-treated Graft versus Host Disease. In: THERAPEUTIC DRUG MONITORING. (pp. 663 - 663). LIPPINCOTT WILLIAMS & WILKINS

C

Cappellini, MD; Perrotta, S; Agaoglu, L; Aydinok, Y; Capra, M; Canatan, D; Drelichman, G; ... Kattamis, A; + view all (2009) Efficacy and Safety of Deferasirox (Exjade (R)) in Patients with beta-Thalassemia Major Treated for up to 5 Years. In: BLOOD. (pp. 1558 - 1559). AMER SOC HEMATOLOGY

Carpenter, JP; Alpendurada, F; Deac, M; Kirk, P; Porter, JB; Walker, JM; Banya, W; ... Pennell, DJ; + view all (2009) Impact of Myocardial Iron Loading On Right Ventricular Function. In: BLOOD. (pp. 794 - 794). AMER SOC HEMATOLOGY

Chaffe, B; Jones, J; Milkins, C; Taylor, C; Asher, D; Glencross, H; Murphy, M; ... UK Transfusion Laboratory Collaborative, ; + view all (2009) UK Transfusion Laboratory Collaborative: recommended minimum standards for hospital transfusion laboratories. Transfus Med , 19 (4) pp. 156-158. 10.1111/j.1365-3148.2009.00938.x.

Chapman, CE; Stainsby, D; Jones, H; Love, E; Massey, E; Win, N; Navarrete, C; ... Serious Hazards of Transfusion Steering Group, ; + view all (2009) Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion , 49 (3) pp. 440-452. 10.1111/j.1537-2995.2008.01948.x.

Cheung, CW; Khwaja, A; (2009) Stromal cell-mediated drug resistance in acute myeloid leukaemia (AML) is attenuated by PI103, a dual inhibitor of Class I PI3-Kinase (PI3K) and mTOR. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 2 - 2). WILEY-BLACKWELL PUBLISHING, INC

Coccia, M; Brooks, SP; Webb, TR; Christodoulou, K; Wozniak, IO; Murday, V; Balicki, M; ... Hardcastle, AJ; + view all (2009) X-linked cataract and Nance-Horan syndrome are allelic disorders. Hum Mol Genet , 18 (14) pp. 2643-2655.

Cohen, H; (2009) Anticoagulation: quality and safety indicators. [Lecture]. Presented at: Institute of healthcare management, London.

Cohen, H; (2009) Effectively implementing the NPSA safety alert. [Lecture]. Presented at: Institute of healthcare management conference on medication errors, London.

Cohen, H; (2009) Late obstetric morbidity in antiphospholipid syndrome. Presented at: VII European Forum on antiphospholipid antibodies, Marseilles.

Cohen, H; (2009) SHOT data 2008 Part 1. [Lecture]. Presented at: SHOT annual symposium, Royal Society of Medicine, London.

Cohen, H; Baglin, T; (2009) Plasma, plasma products and indications for their use. In: Contreras, M, (ed.) ABC of transfusion medicine: british medical journal books. (pp. 40-47). Wiley-Blackwell

Cohen, H; Gates, C; (2009) Anticoagulation therapy: quality and safety indicators. [Lecture]. Presented at: Institute of healthcare management, Manchester.

Cohen, H; Gates, C; (2009) Anticoagulation with dabigatran or rivaroxaban. Drugs and Therapeutics Bulletin , 47 pp. 116-120.

Cohen, H; Gates, C; (2009) New oral agents vs subcutaneous alternatives. Has the DTB drawn the correct conclusion? BMJ online

Cooley, S; Guethlein, L; Trachtenberg, E; Ladner, M; Luo, X; Le, CT; Wang, T; ... Miller, JS; + view all (2009) Selection of Donors with Favorable KIR B Genotypes for Unrelated Hematopoietic Cell Transplantation Results in Superior Relapse Protection and Better Relapse-Free Survival for Patients with AML. In: (Proceedings) 51st Annual Meeting of the American-Society-of-Hematology. (pp. pp. 277-278). AMER SOC HEMATOLOGY

Cooley, S; Parham, P; Trachtenberg, E; Luo, X; Le, CT; Klein, J; Marsh, SGE; ... Miller, JS; + view all (2009) THE RELAPSE-FREE SURVIVAL BENEFIT ASSOCIATED WITH GROUP B KIR HAPLOTYPE DONORS FOR UNRELATED HEMATOPOIETIC CELL TRANSPLANTATION IS UNIQUE TO ACUTE MYELOGENOUS LEUKEMIA. In: (Proceedings) Tandem Meeting on Biology of Blood and Marrow Transplantation. (pp. p. 3). ELSEVIER SCIENCE INC

Cooley, S; Trachtenberg, E; Bergemann, TL; Saeteurn, K; Klein, J; Le, CT; Marsh, SGE; ... Weisdorf, DJ; + view all (2009) Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. BLOOD , 113 (3) pp. 726-732. 10.1182/blood-2008-07-171926.

Cybulla, M; Walter, KN; Schwarting, A; DiVito, R; Feriozzi, S; Sunder-Plassmann, G; (2009) Kidney transplantation in patients with Fabry disease. TRANSPLANT INTERNATIONAL , 22 (4) pp. 475-481. 10.1111/j.1432-2277.2008.00824.x.

D

Davies, TD; Taylor, C; Jones, H; Cohen, H; (2009) Serious hazards of transfusion (SHOT) near miss reporting. In: (Proceedings) British society for haematology annual scientific meeting.

Davies, TD; Taylor, C; Jones, H; Cohen, H; (2009) Serious hazards of transfusion (SHOT) reports relating to anti-D immunoglobulin. In: (Proceedings) British society for haematology annual scientific meeting.

Denard, J; Rundwasser, S; Laroudie, N; Gonnet, F; Naldini, L; Radrizzani, M; Galy, A; ... Svinartchouk, F; + view all (2009) Quantitative proteomic analysis of lentiviral vectors using 2-DE. Proteomics , 9 (14) pp. 3666-3676. 10.1002/pmic.200800747.

Dignan, FL; Anthias, C; Ethell, ME; Morilla, R; Morilla, A; Davies, FE; Morgan, GJ; ... Shaw, BE; + view all (2009) The Presence of Minimal Residual Disease Pre- and Post-Transplant Is Predictive of Outcome in Recipients of Allogeneic Transplantation for Acute Myeloid Leukaemia. In: BLOOD. (pp. 1020 - 1021). AMER SOC HEMATOLOGY

Dignan, FL; Evans, SO; Ethell, ME; Shaw, BE; Davies, FE; Dearden, CE; Treleaven, JG; ... Potter, MN; + view all (2009) An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality. BONE MARROW TRANSPL , 44 (1) 51 - 56. 10.1038/bmt.2008.427.

E

Edinger, M; Powrie, F; Chakraverty, R; (2009) Regulatory Mechanisms in Graft-versus-Host Responses. Biology of Blood and Marrow Transplantation , 15 (1 SUPPL.) pp. 2-6. 10.1016/j.bbmt.2008.10.013.

Emuss, V; Lagos, D; Pizzey, A; Gratrix, F; Henderson, SR; Boshoff, C; (2009) KSHV Manipulates Notch Signaling by DLL4 and JAG1 to Alter Cell Cycle Genes in Lymphatic Endothelia. PLoS Pathogens , 5 (10) , Article e1000616. 10.1371/journal.ppat.1000616. Green open access
file

Everington, T.; (2009) Investigation of the molecular and functional pathophysiology of polycythaemia vera. Doctoral thesis , UCL (University College London).

F

FOLEY, JH; NESHEIM, ME; (2009) Soluble thrombomodulin partially corrects the premature lysis defect in FVIII-deficient plasma by stimulating the activation of thrombin activatable fibrinolysis inhibitor. Journal of Thrombosis and Haemostasis , 7 (3) pp. 453-459. 10.1111/j.1538-7836.2008.03261.x.

Fallah-Arani, F; Sivakumaran, J; Flutter, BR; Bennett, C; Chakraverty, R; (2009) Host CD11c(+) Dendritic Cells Are Required for Priming the Lympho-Haematopoietic Graft-Versus-Host Response but Not Graft-Versus-Host Disease. In: BLOOD. (pp. 966 - 967). AMER SOC HEMATOLOGY

Fielding, AK; Rowe, JM; Richards, SM; Buck, G; Moorman, AV; Durrant, IJ; Marks, DI; ... Goldstone, AH; + view all (2009) Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993. BLOOD , 113 (19) 4489 - 4496. 10.1182/blood-2009-01-199380.

Fiore, MM; Mackie, IJ; (2009) Dual effect of Platelet Factor 4 on the activities of Factor Xa. BIOCHEM BIOPH RES CO , 379 (4) 1072 - 1075. 10.1016/j.bbrc.2009.01.016.

Fiore, MM; Mackie, IM; (2009) Mechanism of low-molecular-weight heparin reversal by platelet factor 4. THROMBOSIS RESEARCH , 124 (1) pp. 149-155. 10.1016/j.thromres.2008.12.047.

G

GUPTA, R; Vyas, P; Enver, T; (2009) Molecular targeting of cancer stem cells. Cell Stem Cell , 5 (2) pp. 125-126. 10.1016/j.stem.2009.07.006.

Garbowski, MW; Carpenter, JP; Smith, G; Pennell, DJ; Porter, JB; (2009) Calibration of Improved T2*Method for the Estimation of Liver Iron Concentration in Transfusional Iron Overload. In: BLOOD. (pp. 791 - 791). AMER SOC HEMATOLOGY

Garbowski, MW; Fabre, M; Evans, P; Porter, JB; (2009) Vitamin C Status in Transfusionally Iron-Overloaded Patients On Long-Term Deferasirox and Its Relationship to Myocardial Iron Removal. In: BLOOD. (pp. 792 - 792). AMER SOC HEMATOLOGY

Gardiner, C; Longair, I; Pescott, MA; Erwin, H; Hills, J; Machin, SJ; Cohen, H; (2009) Self-monitoring of oral anticoagulation: does it work outside trial conditions? Journal of Clinical Pathology , 62 (2) 168 - 171. 10.1136/jcp.2008.059634. Green open access
file

Gardiner, C; Machin, S; Mackie, I; (2009) Point-of-Care Testing in Hemostasis. In: Quality in Laboratory Hemostasis and Thrombosis. (pp. 72-80).

Gerrard, G; Butters, TD; Ganeshaguru, K; Mehta, AB; (2009) Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity. EUROPEAN JOURNAL OF PHARMACOLOGY , 609 (1-3) pp. 34-39. 10.1016/j.ejphar.2009.03.018.

Gordon, WR; Roy, M; Vardar-Ulu, D; Garfinkel, M; Mansour, MR; Aster, JC; Blacklow, SC; (2009) Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL. BLOOD , 113 (18) pp. 4381-4390. 10.1182/blood-2008-08-174748.

Green, CL; Koo, KK; Hills, RK; Burnett, AK; Linch, DC; Gale, RE; (2009) PROGNOSTIC SIGNIFICANCE OF CEBPA MUTATIONS IN A LARGE COHORT OF YOUNGER ADULT PATIENTS WITH AML: IMPACT OF DOUBLE CEBPA MUTATIONS AND THE INTERACTION WITH FLT3 AND NPM1 MUTATIONS. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 431 - 431). FERRATA STORTI FOUNDATION Gold open access

Grimwade, D; Jovanovic, JV; Hills, RK; Nugent, EA; Patel, Y; Flora, R; Diverio, D; ... Burnett, AK; + view all (2009) Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy. J CLIN ONCOL , 27 (22) 3650 - 3658. 10.1200/JCO.2008.20.1533.

Gupta, R; Vyas, P; Enver, T; (2009) Molecular Targeting of Cancer Stem Cells. CELL STEM CELL , 5 (2) pp. 125-126. 10.1016/j.stem.2009.07.006.

H

Hancock, BW; Qian, W; Linch, D; Delchier, J-C; Smith, P; Jakupovic, I; Burton, C; ... Zucca, E; + view all (2009) Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial. BRITISH JOURNAL OF HAEMATOLOGY , 144 (3) pp. 367-375. 10.1111/j.1365-2141.2008.07486.x.

Hernandez, D; Janmohamed, A; Chandan, P; Omar, BA; Phillips, IR; Shephard, EA; (2009) Deletion of the mouse Fmo1 gene results in enhanced pharmacological behavioural responses to imipramine. PHARMACOGENETICS AND GENOMICS , 19 (4) pp. 289-299. 10.1097/FPC.0b013e328328d507.

Hillmen, P; Gribben, JG; Follows, GA; Milligan, DW; Sayala, HA; Moreton, P; Oscier, D; ... Pocock, C; + view all (2009) An Open-Label Phase II Study to Investigate the Safety and Efficacy of Rituximab Plus Chlorambucil in Previously Untreated Patients with CD20-Positive B-Cell Chronic Lymphocytic Leukaemia (CLL). In: BLOOD. (pp. 1331 - 1332). AMER SOC HEMATOLOGY

Holdsworth, R; Hurley, CK; Marsh, SGE; Lau, M; Noreen, HJ; Kempenich, JH; Setterholm, M; (2009) The HLA dictionary 2008: a summary of HLA-A, -B, -C,-DRB1/3/4/5, and-DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. TISSUE ANTIGENS , 73 (2) pp. 95-170. 10.1111/j.1399-0039.2008.01183.x.

Holmes, AM; Reed, MC; Baker, RJ; Jeevaratnam, P; Mehta, AB; Hughes, DA; (2009) Changes in left ventricular posterior wall thickness after treatment with enzyme replacement therapy and effect upon the Mainz Severity Score Index in patients with Fabry disease. Presented at: UNSPECIFIED.

Holmes, MV; Mehta, A; Morgan, MY; (2009) Hemiparesis in a 36 year old man. BMJ (Online) , 338 (7691) 419-. 10.1136/bmj.b90.

Holroyd, A; Townsend, W; Naik, P; Mackinnon, S; Howell, D; Goldstone, A; Linch, D; ... Morris, E; + view all (2009) Favourable outcome for allogeneic haematopoietic transplant recipients requiring intensive therapy unit admission with improved survival following reduced intensity conditioning. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 42 - 42). WILEY-BLACKWELL PUBLISHING, INC

Holroyd, A; Townsend, W; Naik, P; Mackinnon, S; Howell, D; Goldstone, A; Linch, D; ... Morris, E; + view all (2009) Favourable outcome for haematopoietic transplant recipients requiring intensive therapy unit admission: a 10-year single-centre experience. In: BONE MARROW TRANSPLANTATION. (pp. S23 - S23). NATURE PUBLISHING GROUP

Hoskin, PJ; Lowry, L; Horwich, A; Jack, A; Mead, B; Hancock, BW; Smith, P; ... Johnson, PWM; + view all (2009) Randomized Comparison of the Stanford V Regimen and ABVD in the Treatment of Advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244. In: (Proceedings) 50th Annual Meeting of the American-Society-of-Hematology. (pp. pp. 5390-5396). AMER SOC CLINICAL ONCOLOGY

Hough, R; Cooper, N; Veys, P; (2009) Allogeneic haemopoietic stem cell transplantation in children: what alternative donor should we choose when no matched sibling is available? BRITISH JOURNAL OF HAEMATOLOGY , 147 (5) pp. 593-613. 10.1111/j.1365-2141.2009.07841.x.

Hughes, C; Mcewan, JR; Longair, I; Hughes, S; Cohen, H; Machin, S; Scully, M; (2009) Cardiac involvement in acute thrombotic thrombocytopenic purpura: association with troponin T and IgG antibodies to ADAMTS 13. J THROMB HAEMOST , 7 (4) 529 - 536. 10.1111/j.1538-7836.2009.03285.x.

Hughes, D; (2009) The Management of Gaucher Disease as a Chronic Disorder. In: CLINICAL THERAPEUTICS. (pp. S182 - S182). ELSEVIER

Hughes, DA; (2009) Enzyme, substrate, and myeloma in Gaucher Disease. AM J HEMATOL , 84 (4) 199 - 201. 10.1002/ajh.21375.

Hughes, DA; Deegan, PB; Barba Romero, M-A; Giugliani, R; (2009) RESPONSES OF FEMALES WITH FABRY DISEASE TO ERT: COMPARISON WITH MALES, USING DATA FROM FOS - THE FABRY OUTCOME SURVEY. Presented at: 11th International Conference of Inborn Errors of Metabolism, San Diego, CA.

K

Kaput, J; Cotton, RG; Hardman, L; Watson, M; Al Aqeel, AI; Al-Aama, JY; Al-Mulla, F; ... Yeom, YI; + view all (2009) Planning the human variome project: the Spain report. pp. 496-510.

Kaput, J; Cotton, RGH; Hardman, L; Watson, M; Al Aqeel, AI; Al-Aama, JY; Al-Mulla, F; ... Human Variome Project Planning, ; + view all (2009) Planning the Human Variome Project: The Spain Report. HUM MUTAT , 30 (4) 496 - 510. 10.1002/humu.20972.

Kim, BS; Miyagawa, F; Cho, Y-H; Bennett, CL; Clausen, BE; Katz, SI; (2009) Keratinocytes Function as Accessory Cells for Presentation of Endogenous Antigen Expressed in the Epidermis. JOURNAL OF INVESTIGATIVE DERMATOLOGY , 129 (12) pp. 2805-2817. 10.1038/jid.2009.176.

Kirk, P; Roughton, M; Porter, JB; Walker, JM; Tanner, MA; Patel, J; Wu, D; ... Pennell, DJ; + view all (2009) Cardiac T2* magnetic resonance for prediction of cardiac complications in Thalassemia Major. Circulation , 120 (20) pp. 1961-1968. 10.1161/CIRCULATIONAHA.109.874487.

Kirk, P; Roughton, M; Porter, JB; Walker, JM; Tanner, MA; Patel, J; Wu, D; ... Pennell, DJ; + view all (2009) Cardiac T2*Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major. CIRCULATION , 120 (20) 1961 - U23. 10.1161/CIRCULATIONAHA.109.874487.

Kirwan, M; Beswick, R; Vulliamy, T; Nathwani, AC; Walne, AJ; Casimir, C; Dokal, I; (2009) Exogenous TERC alone can enhance proliferative potential, telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patients. BRIT J HAEMATOL , 144 (5) 771 - 781. 10.1111/j.1365-2141.2008.07516.x.

Kishnani, PS; DiRocco, M; Kaplan, P; Mehta, A; Pastores, GM; Smith, SE; Puga, AC; (2009) A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1. Molecular genetics and metabolism 10.1016/j.ymgme.2008.12.015.

Knight, A; Mackinnon, S; Lowdell, MW; (2009) CMV-Reactive Gamma/Delta T Cells Expanded From CMV Seronegative Normal Healthy Individuals Lyse CMV-Infected Targets - Potential Adoptive Immunotherapy for Recipients of Stem Cell Transplants From CMV Seronegative Donors. In: BLOOD. (pp. 880 - 880). AMER SOC HEMATOLOGY

Kolman, P; Pica, A; Carvou, N; Boyde, A; Cockcroft, S; Loesch, A; Pizzey, A; ... Unwin, RJ; + view all (2009) Insulin uptake across the luminal membrane of the rat proximal tubule in vivo and in vitro. AM J PHYSIOL-RENAL , 296 (5) F1227 - F1237. 10.1152/ajprenal.90351.2008.

Krishnamurthy, S; Shaw, BE; Byrne, J; Seedhouse, C; Mayor, N; Madrigal, JA; Russell, N; (2009) A caspase8 promoter polymorphism is associated with increased TRM and reduced survival following T-cell depleted unrelated donor transplantation using alemtuzumab. In: BONE MARROW TRANSPLANTATION. (pp. S79 - S80). NATURE PUBLISHING GROUP

Kwiatkowski, JL; Kim, HY; Thompson, AA; Quinn, CT; Mueller, BU; Odame, I; Giardina, PJ; ... Neufeld, EJ; + view all (2009) Chelation Choices and Iron Burden Among Patients with Thalassemia in the 21st Century: a Report From the Thalassemia Clinical Research Network (TCRN) Longitudinal Cohort. In: BLOOD. (pp. 1555 - 1556). AMER SOC HEMATOLOGY

Kyriakou, C; Canals, C; Finke, J; Kobbe, G; Harousseau, J-L; Kolb, H-J; Novitzky, N; ... Schmitz, N; + view all (2009) Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation. J Clin Oncol , 27 (24) pp. 3951-3958. 10.1200/JCO.2008.20.4628.

L

Lambert, J; Linch, DC; Gale, RE; (2009) MULTIPLE JAK2 V617F MUTATIONS ARE PRESENT IN MOST PATIENTS WITH ESSENTIAL THROMBOCYTHAEMIA: A NEW DISEASE PARADIGM. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 421 - 421). FERRATA STORTI FOUNDATION Gold open access

Lambert, JR; Everington, T; Linch, DC; Gale, RE; (2009) In essential thrombocythemia, multiple JAK2-V617F clones are present in most mutant-positive patients: a new disease paradigm. BLOOD , 114 (14) 3018 - 3023. 10.1182/blood-2009-03-209916.

Lambert, JR; Gale, RE; Linch, DC; (2009) The production of JAK2 wild-type platelets is not downregulated in patients with JAK2 V617F mutant-positive essential thrombocythaemia. BRIT J HAEMATOL , 145 (1) 128 - 130. 10.1111/j.1365-2141.2009.07597.x.

Lawrie, AS; Albanyan, A; Cardigan, RA; Mackie, IJ; Harrison, P; (2009) Microparticle sizing by dynamic light scattering in fresh-frozen plasma. VOX SANG , 96 (3) 206 - 212. 10.1111/j.1423-0410.2008.01151.x.

Leclerc, X; Danos, O; Scherman, D; Kichler, A; (2009) A comparison of synthetic oligodeoxynucleotides, DNA fragments and AAV-1 for targeted episomal and chromosomal gene repair. BMC Biotechnol , 9 35-. 10.1186/1472-6750-9-35.

Lee, CA; Chi, C; Shiltagh, N; Pollard, D; Griffioen, A; Dunn, N; Kadir, RA; (2009) Review of a multidisciplinary clinic for women with inherited bleeding disorders. HAEMOPHILIA , 15 (1) 359 - 360. 10.1111/j.1365-2516.2008.01824.x.

Linker, C; De Almeida, I; Papanayotou, C; Stower, M; Sabado, V; Ghorani, E; Streit, A; ... Stern, CD; + view all (2009) Cell communication with the neural plate is required for induction of neural markers by BMP inhibition: evidence for homeogenetic induction and implications for Xenopus animal cap and chick explant assays. DEV BIOL , 327 (2) 478 - 486. 10.1016/j.ydbio.2008.12.034. Gold open access

Lowdell, MW; Morris, E; (2009) Recent advances in clinical cellular immunotherapy. In: Practical Transfusion Medicine: Third Edition. (pp. 462-468).

M

Mackall, C; Fry, T; Gress, R; Peggs, K; Storek, J; Toubert, A; (2009) Background to hematopoietic cell transplantation, including post transplant immune recovery. BONE MARROW TRANSPL , 44 (8) 457 - 462. 10.1038/bmt.2009.255.

Majumder, B; Lowdell, M; Smith, C; Rakhit, RD; (2009) Differential expression of local versus systemic platelet-monocyte complexes in the circulation of patients with acute coronary syndrome. In: (pp. pp. 197-198). OXFORD UNIV PRESS

Mamopoulos, AM; Hughes, DA; Tuck, SM; Mehta, AB; (2009) Gaucher disease and pregnancy. JOURNAL OF OBSTETRICS AND GYNAECOLOGY , 29 (3) pp. 240-242. 10.1080/01443610902754398.

Mansour, MR; (2009) Oncogenic Kras and Notch-1 cooperate in T-cell acute lymphoblastic leukemia/lymphoma. EXPERT REVIEW OF HEMATOLOGY , 2 (2) pp. 133-136. 10.1586/EHM.09.3.

Mansour, MR; Sulis, ML; Duke, V; Foroni, L; Jenkinson, S; Koo, K; Allen, CG; ... Linch, DC; + view all (2009) Prognostic Implications of NOTCH1 and FBXW7 Mutations in Adults With T-Cell Acute Lymphoblastic Leukemia Treated on the MRC UKALLXII/ECOG E2993 Protocol. J CLIN ONCOL , 27 (26) 4352 - 4356. 10.1200/JCO.2009.22.0996.

Mantovani, J; Charrier, S; Eckenberg, R; Saurin, W; Danos, O; Perea, J; Galy, A; (2009) Diverse genomic integration of a lentiviral vector developed for the treatment of Wiskott-Aldrich syndrome. J Gene Med , 11 (8) pp. 645-654. 10.1002/jgm.1346.

Marks, DI; Paietta, EM; Moorman, AV; Richards, SM; Buck, G; DeWald, G; Ferrando, A; ... Lazarus, HM; + view all (2009) T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). BLOOD , 114 (25) 5136 - 5145. 10.1182/blood-2009-08-231217.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update April 2009. TISSUE ANTIGENS , 74 (3) pp. 272-275. 10.1111/j.1399-0039.2009.01322.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update August 2008. TISSUE ANTIGENS , 73 (1) pp. 91-92. 10.1111/j.1399-0039.2008.01165.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update December 2008. TISSUE ANTIGENS , 73 (6) pp. 629-631. 10.1111/j.1399-0039.2009.01242.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update February 2009. TISSUE ANTIGENS , 74 (2) pp. 180-182. 10.1111/j.1399-0039.2009.01285.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update January 2009. TISSUE ANTIGENS , 74 (2) pp. 177-179. 10.1111/j.1399-0039.2009.01284.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update July 2008. TISSUE ANTIGENS , 73 (1) pp. 88-90. 10.1111/j.1399-0039.2008.01164.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update June 2009. TISSUE ANTIGENS , 74 (4) pp. 364-366. 10.1111/j.1399-0039.2009.01330.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update March 2009. TISSUE ANTIGENS , 74 (2) pp. 183-186. 10.1111/j.1399-0039.2009.01288.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update May 2009. TISSUE ANTIGENS , 74 (4) pp. 358-363. 10.1111/j.1399-0039.2009.01321.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update November 2008. TISSUE ANTIGENS , 73 (4) pp. 383-384. 10.1111/j.1399-0039.2009.01212.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update October 2008. TISSUE ANTIGENS , 73 (4) pp. 381-382. 10.1111/j.1399-0039.2009.01211.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update September 2008. TISSUE ANTIGENS , 73 (1) pp. 93-94. 10.1111/j.1399-0039.2008.01169.x.

Marthandan, N; Karp, DR; Amett, F; Waller, MJ; Guidry, P; Feolo, M; Marsh, SGE; (2009) HLA genetic association analysis using the sequence feature variant type approach. JOURNAL OF IMMUNOLOGY , 182

Mattar, CN; Dighe, NM; Waddington, SN; McIntosh, J; Biswas, A; Fisk, NM; Davidoff, AM; ... Chan, J; + view all (2009) Long-Term Transgene Expression in New-Born Cynomolgus Macaques Following Intra-Uterine Gene Transfer of Self-Complementary AAV. In: MOLECULAR THERAPY. (pp. S117 - S117). NATURE PUBLISHING GROUP

Mayor, N; Shaw, BE; Cooke, L; Marsh, S; Madrigal, JA; (2009) The impact of NOD2/CARD15 SNP 5 on the outcome of unrelated donor haematopoietic stem cell transplantation for acute lymphoblastic leukaemia. In: BONE MARROW TRANSPLANTATION. (pp. S203 - S203). NATURE PUBLISHING GROUP

Mayor, NP; Shaw, BE; Cooke, L; Madrigal, JA; Marsh, SGE; (2009) Predicting disease relapse using NOD2/CARD15 SNP5 and HLA-DPB1 matching status. INT J IMMUNOGENET , 36 (5) 317 - 318.

Mayor, NP; Shaw, BE; Cooke, L; Madrigal, JA; Marsh, SGE; (2009) The impact of NOD2/CARD15 SNP 5 on the outcome of unrelated donor hematopoietic stem cell transplantation for acute lymphoblastic leukaemia. In: TISSUE ANTIGENS. (pp. 403 - 403). WILEY-BLACKWELL PUBLISHING, INC

McCabe, DJH; Starke, R; Harrison, P; Brown, MM; Sidhu, PS; Mackie, IJ; Machin, SJ; (2009) ADAMTS-13 (VON WILLEBRAND FACTOR-CLEAVING PROTEASE) ACTIVITY IN THE EARLY AND LATE PHASES AFTER TRANSIENT ISCHAEMIC ATTACK OR ISCHAEMIC STROKE. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 103 - 104). B M J PUBLISHING GROUP

McClelland, B; Cohen, H; McClelland, B; (2009) Risks of transfusion in the context of haemovigilance: SHOT - the UK haemovigilance system. In: ABC of transfusion medicine: british medical journal books. (pp. 83-88). Wiley-Blackwell

McDonald, V; Scully, M; Manns, K; Mackie, IJ; Machin, SJ; (2009) Serum rituximab levels in TTP: the effect of plasma exchange and correlation with response to treatment. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 5 - 5). WILEY-BLACKWELL PUBLISHING, INC

Mead, A.J.; (2009) The clinical and biological consequences of different FLT3 mutations in patients with AML. Doctoral thesis , UCL (University College London). Green open access
file

Mednick, L; Yu, SL; Trachtenberg, F; Kleinert, DA; Giardina, PJ; Kwiatkowski, JL; Foote, D; ... Yamashita, R; + view all (2009) Symptoms of Anxiety and Depression Among Teens and Adults in the Thalassemia Longitudinal Cohort Study. In: BLOOD. (pp. 231 - 232). AMER SOC HEMATOLOGY

Mehta, A; (2009) Eighth International Symposium on Lysosomal Storage Diseases. International Journal of Clinical Pharmacology and Therapeutics , 47 (supp 1) S1-S3.

Mehta, A; (2009) Psychosocial aspects of Fabry disease and their impact on optimal disease management. Clinical Therapeutics , 31 s1-s2.

Mehta, A; Clarke, JTR; Giugliani, R; Elliott, P; Linhart, A; Beck, MS-PG; (2009) Natural course of Fabry disease: changing pattern of causes of death in FOS – Fabry Outcome Survery. Journal of Medical Genetics , 46 pp. 548-552. 10.1136/jmg.2008.065904.

Mehta, A; Hoffbrand, A; (2009) Haematology at a Glance. [Book]. (3rd ed.). Blackwell Wiley

Mehta, AB; (2009) Anderson – Fabry Disease : developments in diagnosis and therapy. International Journal of Clinical Pharmacology and Therapeutics , 47 (1) s66-s74.

Mehta, AB; (2009) Common hereditary lysosomal storage disorders. BMJ Point of Care

Meys, R; Fowles, F; Little, A; Marsh, SG; Asboe, D; Hawkins, DA; Gotch, FM; (2009) Immunogenetics of HIV associated HPV disease after HAART. In: (Proceedings) 69th Annual Meeting of the Society-of-Investigative-Dermatology. (pp. S82-S82). NATURE PUBLISHING GROUP

Middleton, D; Gonzalez, F; Fernandez-Vina, M; Tiercy, J-M; Marsh, SGE; Aubrey, M; Bicalho, MG; ... Yang, KL; + view all (2009) A bioinformatics approach to ascertaining the rarity of HLA alleles. TISSUE ANTIGENS , 74 (6) pp. 480-485. 10.1111/j.1399-0039.2009.01361.x.

Mikosch, P; Reed, M; Stettner, H; Baker, R; Mehta, AB; Hughes, DA; (2009) Patients with Gaucher disease living in England show a high prevalence of vitamin D insufficiency with correlation to osteodensitometry. MOLECULAR GENETICS AND METABOLISM , 96 (3) pp. 113-120. 10.1016/j.ymgme.2008.12.001.

Mohamedbhai, SG; Lowry, L; Goldstone, AH; Linch, DC; Ardeshna, KM; (2009) Rituximab in combination with CODOX-M/IVAC: toxicity and efficacy in 17 adults with non-HIV related B-cell non-Hodgkin lymphomas with 495% proliferation index. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 15 - 16). WILEY-BLACKWELL PUBLISHING, INC

Morris, EC; Thomson, KJ; (2009) Bone marrow and stem cell transplantation. Medicine , 37 (3) pp. 168-171. 10.1016/j.mpmed.2009.01.001.

Morris, T; Oakervee, H; Kettle, P; Drake, M; Brunton, A; Cook, G; Leahy, M; ... Cavenagh, J; + view all (2009) The PAD (Ireland) Study for Patients with Refractory and Relapsed Myeloma: An Update. CLINICAL LYMPHOMA & MYELOMA , 9 S27-S27.

Morris, TCM; Kettle, P; Drake, M; Brunton, A; Cook, G; Leahy, M; O'Dwyer, M; ... Cavenagh, J; + view all (2009) Bortezomib, adriamycin and dexamethasone for patients with refractory and relapsed myeloma - results from the PAD (Ireland) study. In: (Proceedings) 49th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 16). WILEY-BLACKWELL PUBLISHING, INC

Morris, TCM; Kettle, P; Drake, M; Quinn, M; Cavet, J; Tighe, J; Kazmi, M; ... Popat, R; + view all (2009) Good response rates following second autologous transplantation after bortezomib-based re-induction therapy. In: (Proceedings) 49th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 87). WILEY-BLACKWELL PUBLISHING, INC

N

Nagao, K; Ginhoux, F; Leitner, WW; Motegi, S-I; Bennett, CL; Clausen, BE; Merad, M; (2009) Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 106 (9) pp. 3312-3317. 10.1073/pnas.0807126106.

Nathwani, AC; Cochrane, M; McIntosh, J; Ng, CYC; Zhou, J; Gray, JT; Davidoff, AM; (2009) Enhancing transduction of the liver by adeno-associated viral vectors. GENE THER , 16 (1) 60 - 69. 10.1038/gt.2008.137.

O

Orteu, CH; Mehta, AB; Dhoat, S; Hughes, DA; (2009) Fabry disease and angiokeratoma corporis diffusum are not synonymous: cutaneous vascular lesions and facial features in 100 patients with Fabry disease. Presented at: 89th Annual Meeting of the British-Association-of-Dermatologists, Glasgow, SCOTLAND.

Orti, G; Lowdell, M; Fielding, A; Samuel, E; Pang, K; Kottaridis, P; Morris, E; ... Chakraverty, R; + view all (2009) Phase I Study of High-Stringency CD8 Depletion of Donor Leukocyte Infusions After Allogeneic Hematopoietic Stem Cell Transplantation. TRANSPLANTATION , 88 (11) 1312 - 1318. 10.1097/TP.0b013e3181bbf382.

Osman, E; Evans, V; Graham, IR; Athanasopoulos, T; McIntosh, J; Nathwani, AC; Simons, JP; ... Owen, JS; + view all (2009) Preliminary evaluation of a self-complementary AAV2/8 vector for hepatic gene transfer of human apoE3 to inhibit atherosclerotic lesion development in apoE-deficient mice. ATHEROSCLEROSIS , 204 (1) 121 - 126. 10.1016/j.atherosclerosis.2008.08.043.

P

Pastores, GM; Giraldo, P; Cherin, PMA; (2009) Goal-orientated therapy with Miglustat in Gaucher disease. Current Medical Research and Opinion , 25 (1) pp. 23-37. 10.1185/03007990802576518.

Pastores, GM; Hughes, DA; (2009) To see a world in a grain of sand: elucidating the pathophysiology of Anderson-Fabry disease through investigations of a cellular model. KIDNEY INTERNATIONAL , 75 (4) pp. 351-353. 10.1038/ki.2008.606.

Patel, ARC; Jamal, S; Kumar, K; Lear, S; Lowdell, M; Tahami, F; Beckles, M; ... Lipman, MCI; + view all (2009) EVALUATING BRONCHOALVEOLAR LAVAGE CELLULAR PROFILES USING FLOW CYTOMETRY IN PATIENTS WITH PULMONARY AND SYSTEMIC DISEASE. In: THORAX. (pp. A52 - A53). B M J PUBLISHING GROUP

Patel, B; Ghorani, E; Zhang, Y; Gitendra-Wickremasinghe, R; Steele, A; Fielding, AK; (2009) Attenuated Measles Virus: A Promising Therapeutic Modality for B Cell Malignancy. In: BLOOD. (pp. 970 - 970). AMER SOC HEMATOLOGY

Patel, B; Goldstone, AH; Fielding, AK; (2009) Allogeneic Stem Cell Transplantation for acute lymphoblastic leukaemia (ALL). In: Lazarus, H and Laughlin, M, (eds.) Allogeneic Stem Cell Transplantation. Humana Pr Inc

Patel, B; Kirkland, KE; Szydlo, R; Pearce, RM; Clark, RE; Craddock, C; Liakopoulou, E; ... Marks, DI; + view all (2009) Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission. HAEMATOL-HEMATOL J , 94 (10) 1399 - 1406. 10.3324/haematol.2009.008649. Gold open access

Patel, BR; Thompson, J; Zhang, Y; Gitendra-Wickremasinghe, R; Steele, AJ; Fielding, AK; (2009) Differential Effect of Measles Virus Oncolysis in B Cell Malignancies. In: (Proceedings) 12th Annual Meeting of the American Society of Gene Therapy. (pp. S158-S158). NATURE PUBLISHING GROUP

Patel, C; Hughes, D; Jeevaratnam, P; Jennings, A; Milligan, A; Pringle, S; Richfield, L; (2009) CHANGE IN REFERRAL PATTERNS FOR PATIENTS WITH ANDERSON-FABRY DISEASE: A UNITED KINGDOM CENTER'S PERSPECTIVE. Presented at: 9th Annual European Round Table Meeting on Fabry Disease, Athens, GREECE.

Payne, E; Look, T; (2009) Zebrafish modelling of leukaemias. Br J Haematol , 146 (3) pp. 247-256. 10.1111/j.1365-2141.2009.07705.x.

Peggs, KS; (2009) Adoptive T cell immunotherapy for cytomegalovirus. EXPERT OPIN BIOL TH , 9 (6) 725 - 736. 10.1517/14712590902967588.

Peggs, KS; Krauss, A; Mackall, C; (2009) Clinical implications of immune reconstitution following autologous and allogeneic transplantation. In: Bishop, MR, (ed.) Hematopoietic Stem Cell Transplantation. (pp. 131-154). Springer Verlag

Peggs, KS; Krauss, AC; Mackall, CL; (2009) Clinical implications of immune reconstitution following hematopoietic stem cell transplantation. Cancer Treat Res , 144 pp. 131-154. 10.1007/978-0-387-78580-6_6.

Peggs, KS; Quezada, SA; Allison, JP; (2009) Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists. CLIN EXP IMMUNOL , 157 (1) 9 - 19. 10.1111/j.1365-2249.2009.03912.x.

Peggs, KS; Quezada, SA; Chambers, CA; Korman, AJ; Allison, JP; (2009) Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies. J EXP MED , 206 (8) 1717 - 1725. 10.1084/jem.20082492.

Peggs, KS; Quezada, SA; Sharma, P; Allison, JP; (2009) Cancer immunotherapy. In: Hong, WK and Bast, RC and Hait, W and Kufe, DW and Pollock, RE and Holland, JF and Weichselbaum, RR, (eds.) Cancer medicine 8. (pp. 175-189). Pmph USA Ltd

Peggs, KS; Thomson, K; Morris, E; Chowdhry, N; Verfuerth, S; Kottaridis, P; Goldstone, AH; ... Mackinnon, S; + view all (2009) Donor Lymphocyte Infusions Induce High Response Rates and Durable Salvage in Relapsed Hodgkin Lymphoma Post T Cell Depleted Allogeneic Transplantation. In: BLOOD. (pp. 87 - 87). AMER SOC HEMATOLOGY

Peggs, KS; Thomson, K; Samuel, E; Dyer, G; Armoogum, J; Pang, K; Chakraverty, R; ... Lowdell, MW; + view all (2009) Adoptive Transfer of CMV-Specific Donor T Cells Following Allogeneic Transplantation Leads to Rapid and Safe Systemic Reconstitution. In: BLOOD. (pp. 24 - 24). AMER SOC HEMATOLOGY

Peggs, KS; Verfuerth, S; Pizzey, A; Chow, SLC; Thomson, K; Mackinnon, S; (2009) Cytomegalovirus-Specific T Cell Immunotherapy Promotes Restoration of Durable Functional Antiviral Immunity following Allogeneic Stem Cell Transplantation. CLIN INFECT DIS , 49 (12) 1851 - 1860. 10.1086/648422.

Pennell, D; El-Beshlawy, A; Sutcharitchan, P; Elalfy, M; Aydinok, Y; Taher, A; Smith, G; ... Porter, JB; + view all (2009) PREVENTION OF CARDIAC IRON ACCUMULATION WITH ONCE DAILY ORAL DEFERASIROX THERAPY IN REGULARLY TRANSFUSED PATIENTS WITH B THALASSAEMIA MAJOR. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 433 - 434). FERRATA STORTI FOUNDATION Gold open access

Pennell, D; Porter, JB; Cappellini, MD; Chan, LL; El-Beshlawy, A; Aydinok, Y; Ibrahim, H; ... Taher, A; + view all (2009) EFFICACY AND SAFETY OF DEFERASIROX IN REDUCING MYOCARDIAL SIDEROSIS IN PATIENTS WITH B-THALASSAEMIA MAJOR. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 74 - 75). FERRATA STORTI FOUNDATION Gold open access

Pennell, DJ; Porter, JB; Cappellini, MD; Chan, LL; El-Beshlawy, A; Aydinok, Y; Ibrahim, H; ... Taher, A; + view all (2009) Efficacy and Safety of Deferasirox (Exjade (R)) in beta-Thalassemia Patients with Myocardial Siderosis: 2-Year Results From the EPIC Cardiac Sub-Study. In: BLOOD. (pp. 1558 - 1558). AMER SOC HEMATOLOGY

Perera, G; Kassen, D; Nestle, F; (2009) A successful therapeutic model for psoriasis: recapitulation of human psoriasis in a xenotransplantation mouse model. In: BRITISH JOURNAL OF DERMATOLOGY. (pp. 10 - 10). WILEY-BLACKWELL PUBLISHING, INC

Perera, GK; Kassen, D; Nestle, FO; (2009) Investigation of the spatiotemporal expression pattern of the antimicrobial peptide, LL-37, in the development and resolution of psoriasis. In: BRITISH JOURNAL OF DERMATOLOGY. (pp. 904 - 904). WILEY-BLACKWELL PUBLISHING, INC

Popat, R; Oakervee, H; Williams, C; Cook, M; Craddock, C; Basu, S; Singer, C; ... Cavenagh, J; + view all (2009) Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY , 144 (6) pp. 887-894. 10.1111/j.1365-2141.2008.07572.x.

Porter, J; (2009) Blood transfusion: quality and safety issues in thalassemia, basic requirements and new trends. Hemoglobin , 33 Sup S28-S36. 10.3109/03630260903346593.

Porter, JB; (2009) Deferasirox: an update. Hemoglobin , 33 Sup S70-S75. 10.3109/03630260903347146.

Porter, JB; (2009) Iron toxicity: optimizing chelation therapy across transfusion-dependent anaemias Proceedings of a satellite symposium at the 14th Congress of the European Hematology Association (EHA), held in June 2009 in Berlin Introduction. BLOOD REV , 23 S1 - S1.

Porter, JB; (2009) Optimizing iron chelation strategies in beta-thalassaemia major. BLOOD REVIEWS , 23 S3 - S7.

Porter, JB; (2009) Pathophysiology of transfusional iron overload: contrasting patterns in thalassemia major and sickle cell disease. Hemoglobin , 33 Sup S37-S45. 10.3109/03630260903346627.

Porter, JB; Athanasiou-Metaxa, M; Bowden, DK; Troncy, J; Habr, D; Domokos, G; Roubert, B; ... Cappellini, MD; + view all (2009) Improved Patient Satisfaction, Adherence and Health-Related Quality of Life with Deferasirox (Exjade (R)) in beta-Thalassemia Patients Previously Receiving Other Iron Chelation Therapies. In: BLOOD. (pp. 980 - 981). AMER SOC HEMATOLOGY

Porter, JB; Piga, A; Cohen, A; Ford, JM; Bodner, J; Cappellini, MD; (2009) ASSESSMENT OF SAFETY IN PATIENTS RECEIVING LONGER-TERM IRON CHELATION THERAPY WITH DEFERASIROX WHO HAD ACHIEVED SERUM FERRITIN LEVELS OF < 1000 NG/ML DURING THE STUDY COURSE. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 77 - 77). FERRATA STORTI FOUNDATION Gold open access

Porter, JB; Yoon, SS; Shen, ZX; Thein, SL; Lin, KH; Habr, D; Domokos, G; ... Lee, JW; + view all (2009) IRON CHELATION THERAPY WITH DEFERASIROX FOR TRANSFUSIONAL IRON-OVERLOADED PATIENTS WITH APLASTIC ANAEMIA AND OTHER RARE ANAEMIAS. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 80 - 80). FERRATA STORTI FOUNDATION Gold open access

Q

Querol, S; Mufti, GJ; Marsh, SGE; Pagliuca, A; Little, AM; Shaw, BE; Jeffery, R; ... Madrigal, JA; + view all (2009) Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be? HAEMATOL-HEMATOL J , 94 (4) 536 - 541. 10.3324/haematol.2008.002741. Gold open access

Querol, S; Rubinstein, P; Marsh, SGE; Goldman, J; Madrigal, JA; (2009) Cord blood banking: 'providing cord blood banking for a nation'. BRITISH JOURNAL OF HAEMATOLOGY , 147 (2) pp. 227-235. 10.1111/j.1365-2141.2009.07818.x.

Quinn, J; Rabin, N; Rodriguez-Justo, M; Choi, D; Yong, K; (2009) Multiple myeloma presenting with spinal cord compression during pregnancy. pp. 181-182.

Quinn, J; Von Klemperer, K; Brooks, R; Peebles, D; Walker, F; Cohen, H; (2009) Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy: a single-center experience. HAEMATOL-HEMATOL J , 94 (11) 1608 - 1612. 10.3324/haematol.2008.002840. Gold open access

R

Rahim, AA; Wong, AM; Buckley, SM; Hughes, DA; Karlsson, S; Cooper, JD; Thrasher, AJ; ... Waddington, SN; + view all (2009) Fetal Gene Therapy for Acute Neuronopathic Gaucher Disease. In: MOLECULAR THERAPY. (pp. S357 - S357). NATURE PUBLISHING GROUP

Reiss, U; Davidoff, A; Gray, J; Nienhuis, A; Nathwani, A; (2009) Dose response results of self complementary adeno-associated virus (AAV) vector-mediated factor IX gene transfer in non-human primates. HAEMOPHILIA , 15 (2) 635 - 635.

Roberts, CH; Mayor, NP; Madrigal, JA; Marsh, SGE; (2009) Short template amplicon and multiplex megaprimer enabled relay sequencing: a flexible approach to bidirectional and simultaneous sequencing in a single vessel. In: (Proceedings) 23rd European Immunogenetics and Histocompatibility Conference. (pp. p. 398). WILEY-BLACKWELL PUBLISHING, INC

Robinson, J; Roberts, CH; Dodi, IA; Madrigal, JA; Pawelec, G; Wedel, L; Marsh, SGE; (2009) The European searchable tumour line database. CANCER IMMUNOLOGY IMMUNOTHERAPY , 58 (9) pp. 1501-1506. 10.1007/s00262-008-0656-5.

Robinson, J; Waller, MJ; Fail, SC; McWilliam, H; Lopez, R; Parham, P; Marsh, SGE; (2009) The IMGT/HLA database. D1013-D1017.

Robinson, J; Waller, MJ; Fail, SC; McWilliam, H; Lopez, R; Parham, P; Marsh, SGE; (2009) The IMGT/HLA database. NUCLEIC ACIDS RESEARCH , 37 D1013-D1017. 10.1093/nar/gkn662.

Roddie, C; Paul, J; Benjamin, R; Gallimore, C; Xerry, J; Gray, JJ; Peggs, K; ... Ward, K; + view all (2009) Allogeneic haematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognised cause of morbidity. In: BONE MARROW TRANSPLANTATION. (pp. S63 - S63). NATURE PUBLISHING GROUP

Roddie, C; Paul, JPV; Benjamin, R; Gallimore, CI; Xerry, J; Gray, JJ; Peggs, KS; ... Ward, KN; + view all (2009) Allogeneic Hematopoietic Stem Cell Transplantation and Norovirus Gastroenteritis: A Previously Unrecognized Cause of Morbidity. CLIN INFECT DIS , 49 (7) 1061 - 1068. 10.1086/605557.

Roddie, C; Peggs, K; (2009) Hodgkin’s Lymphoma. Medicine , 37 (4) pp. 208-211.

Ryland, JK; Lawrie, AS; Machin, SJ; Mackie, IJ; (2009) Persistent high factor VIII activity leading to increased thrombin generation. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 4 - 4). WILEY-BLACKWELL PUBLISHING, INC

S

Saudemont, A; Garcon, F; Yadi, H; Roche-Molina, M; Kim, N; Segonds-Pichon, A; Martin-Fontecha, A; ... Colucci, F; + view all (2009) p110 gamma and p110 delta isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 106 (14) pp. 5795-5800. 10.1073/pnas.0808594106.

Saunders, RE; Shiltagh, N; Gomez, K; Mellars, G; Cooper, C; Perry, DJ; Tuddenham, EG; (2009) Structural analysis of eight novel and 112 previously reported missense mutations in the interactive FXI mutation database reveals new insight on FXI deficiency. THROMB HAEMOSTASIS , 102 (2) 287 - 301. 10.1160/TH09-01-0044.

Schellekens, J; Schaffer, M; Roberts, CH; Malmberg, K-J; Madrigal, JA; Marsh, SGE; (2009) KIR3DL1 allele typing by sequence-based typing. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 36 (5) p. 316.

Schellekens, J; Schaffer, M; Roberts, CH; Malmberg, K-J; Madrigal, JA; Marsh, SGE; (2009) KIR3DL1 allele typing by sequencing-based typing analysis. In: (Proceedings) 23rd European Immunogenetics and Histocompatibility Conference. (pp. pp. 456-457). WILEY-BLACKWELL PUBLISHING, INC

Schmid, M; Cappellini, MD; Porter, JB; Greenberg, PL; Lawniczek, T; Glaser, S; Dong, V; (2009) Safety of Deferasirox (Exjade (R)) in Myelodysplastic Syndromes (MDS) and Non-MDS Patients with Transfusional Iron Overload: A Pooled Analysis Focusing On Renal Function. In: BLOOD. (pp. 702 - 703). AMER SOC HEMATOLOGY

Shaw, BE; Apperley, J; Russell, NH; Craddock, CF; Liakopoulou, E; Potter, MN; Wynn, R; ... Byrne, JL; + view all (2009) A Comparison of Stem Cell Source in Adult and Paediatric Recipients of T-Cell Depleted Myeloablative Transplants for Standard Risk Leukaemia: No Difference in Mortality Using BM or PBSC. In: BLOOD. (pp. 495 - 496). AMER SOC HEMATOLOGY

Shaw, BE; Fleischhauer, K; Zino, E; Malkki, M; Spellman, S; Morishima, Y; Gooley, T; ... Int Histocompatibility Working Grp, ; + view all (2009) Significant differences in outcome following unrelated donor HCT can be better predicted using an algorithm incorporating both allele and epitope level matching for HLA-DPB1. In: BONE MARROW TRANSPLANTATION. (pp. S78 - S78). NATURE PUBLISHING GROUP

Shaw, BE; Mayor, NP; Russell, NH; Apperley, JF; Clark, RE; Cornish, J; Darbyshire, P; ... Madrigal, JA; + view all (2009) Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. Leukemia

Shaw, BE; Veys, P; Pagliuca, A; Addada, J; Cook, G; Craddock, CF; Gennery, AR; ... Hough, RE; + view all (2009) Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithms. BONE MARROW TRANSPL , 44 (1) 7 - 12. 10.1038/bmt.2008.420.

Shih, CS; Laurie, N; Holzmacher, J; Spence, Y; Nathwani, AC; Davidoff, AM; Dyer, MA; (2009) AAV-mediated Local Delivery of Interferon-beta for the Treatment of Retinoblastoma in Preclinical Models. NEUROMOL MED , 11 (1) 43 - 52. 10.1007/s12017-009-8059-0.

Singh, KJDAL; O'Hare, MJ; Pizzey, A; Appasammy, M; Stein, RC; Muttukrishna, S; (2009) Ovarian Granulosa Cells Have Varying Sensitivity to Different Cytotoxic Drugs Used To Treat Young Breast Cancer Patients. In: (Proceedings) 56th Annual Meeting of the Society-for-Gynecologic-Investigation. (pp. 151A-151A). SAGE PUBLICATIONS INC

Smith, BN; Ancliff, PJ; Pizzey, A; Khwaja, A; Linch, DC; Gale, RE; (2009) Homozygous HAX1 mutations in severe congenital neutropenia patients with sporadic disease: a novel mutation in two unrelated British kindreds. BRIT J HAEMATOL , 144 (5) 762 - 770. 10.1111/j.1365-2141.2008.07493.x.

Smith, BN; Bevan, S; Vance, C; Renwick, P; Wilkinson, P; Proukakis, C; Squitieri, F; ... Shaw, CE; + view all (2009) Four novel SPG3A/atlastin mutations identified in autosomal dominant hereditary spastic paraplegia kindreds with intra-familial variability in age of onset and complex phenotype. CLIN GENET , 75 (5) 485 - 489. 10.1111/j.1399-0004.2009.01184.x.

Sobota, A; Yamashita, R; Xu, Y; Trachtenberg, F; Kleinert, DA; Giardina, PJ; Kwiatkowski, JL; ... Neufeld, EJ; + view all (2009) Quality of Life in Adolescents and Adults with Thalassemia: A Report of the Thalassemia Longitudinal Cohort. In: BLOOD. (pp. 232 - 232). AMER SOC HEMATOLOGY

Sorio, C; Martinelli, GV; Monne, M; Vezzalini, M; Moratti, E; Mafficini, A; Della Peruta, M; (2009) DOWN-REGULATION OF PROTEIN TYROSINE PHOSPHATASE GAMMA (PTPRG) IN CHRONIC MYELOID LEUKEMIA (CML). In: ANNALS OF ONCOLOGY. (pp. 39 - 39). OXFORD UNIV PRESS

Steele, A; Prentice, AG; Chanalaris, A; Hoffbrand, AV; Cwynarski, K; Wickremasinghe, R; (2009) Induction of Noxa Via Generation of Reactive Oxygen Species Plays a Key Role in Induction of CLL Cell Apoptosis by Two Novel p53-Independent Cytotoxic Agents. In: (Proceedings) 51st Annual Meeting of the American-Society-of-Hematology. (pp. p. 1076). AMER SOC HEMATOLOGY

Steele, AJ; Prentice, AG; Cwynarski, K; Hoffbrand, AV; Wickremasinghe, RG; (2009) 2-phenylacetylenesulphonamide induces p53-independent apoptosis of CLL cells via upregulation of the BH3 protein Noxa. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 1 - 1). WILEY-BLACKWELL PUBLISHING, INC

Steele, AJ; Prentice, AG; Hoffbrand, AV; Yogashangary, BC; Hart, SM; Lowdell, MW; Samuel, ER; ... Wickremasinghe, RG; + view all (2009) 2-Phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. Blood , 114 (6) pp. 1217-1225. 10.1182/blood-2008-11-190587.

Steele, AJ; Prentice, AG; Hoffbrand, AV; Yogashangary, BC; Hart, SM; Lowdell, MW; Samuel, ER; ... Wickremasinghe, RG; + view all (2009) 2-Phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. Blood , 114 (6) pp. 1217-1225. 10.1182/blood-2008-11-190587.

Steele, AJ; Prentice, AG; Hoffbrand, AV; Yogashangary, BC; Hart, SM; Lowdell, MW; Samuel, ER; ... Wickremasinghe, RG; + view all (2009) 2-phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. BLOOD , 114 (6) 1217 - 1225. 10.1182/blood-2008-11-190587.

Steele, AJ; Prentice, AG; Hoffbrand, AV; Yogashangary, BC; Hart, SM; Lowdell, MW; Samuel, ER; ... Wickremasinghe, RG; + view all (2009) 2-phenylacetylenesulfonamide(PAS) induces p53-independent killing of B-chronic lymphocytic leukemia(CLL) cells. Blood , 114 (6) pp. 1217-1225.

Stieger, K; Lhériteau, E; Moullier, P; Rolling, F; (2009) AAV-mediated gene therapy for retinal disorders in large animal models. ILAR J , 50 (2) pp. 206-224. 10.1093/ilar.50.2.206.

T

Taher, A; Cappellini, MD; Vichinsky, E; Galanello, R; Piga, A; Lawniczek, T; Clark, J; ... Porter, JB; + view all (2009) Efficacy and safety of deferasirox doses of > 30 mg/kg per d in patients with transfusion-dependent anaemia and iron overload. BRIT J HAEMATOL , 147 (5) 752 - 759. 10.1111/j.1365-2141.2009.07908.x.

Taher, A; Koren, A; Tamary, H; Cappellini, MD; Porter, JB; Habr, D; Domokos, G; ... Viprakasit, V; + view all (2009) EFFICACY AND SAFETY OF DEFERASIROX IN CHELATION-NAIVE PATIENTS WITH B-THALASSAEMIA MAJOR: RESULTS FROM THE LARGE-SCALE EPIC STUDY. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 313 - 314). FERRATA STORTI FOUNDATION Gold open access

Tan, MH; Smith, AJ; Pawlyk, B; Xu, XY; Liu, XQ; Bainbridge, JB; Basche, M; ... Ali, RR; + view all (2009) Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors. Human Molecular Genetics , 18 (12) 2099 - 2114. 10.1093/hmg/ddp133. Green open access
file

Taylor, C; Cohen, H; Mold, D; Jones, H; (2009) The 2008 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Thephinlap, C; Phisalaphong, C; Fucharoen, S; Porter, JB; Srichairatanakool, S; (2009) Efficacy of Curcuminoids in Alleviation of Iron Overload and Lipid Peroxidation in Thalassemic Mice. MED CHEM , 5 (5) 474 - 482.

Thomson, K; Kottaridis, P; Morris, E; Chakraverty, R; Peggs, K; Mackinnon, S; (2009) Successful myeloablative transplantation in high-risk acute myeloid leukaemia using unrelated donors with alemtuzumab for T-cell depletion. In: BONE MARROW TRANSPLANTATION. (pp. S88 - S88). NATURE PUBLISHING GROUP

Thomson, KJ; Morris, EC; Bloor, A; Cook, G; Milligan, D; Parker, A; Clark, F; ... Mackinnon, S; + view all (2009) Favorable Long-Term Survival After Reduced-Intensity Allogeneic Transplantation for Multiple-Relapse Aggressive Non-Hodgkin's Lymphoma. Journal of Clinical Oncology , 27 (3) 426 - 432. 10.1200/JCO.2008.17.3328.

Tosello, V; Mansour, MR; Barnes, K; Paganin, M; Sulis, ML; Jenkinson, S; Allen, CG; ... Ferrando, AA; + view all (2009) WT1 mutations in T-ALL. BLOOD , 114 (5) 1038 - 1045. 10.1182/blood-2008-12-192039.

Townsend, W; Cross, NCP; Waghorn, K; Somana, K; Ramsay, A; Thomson, K; Peggs, K; (2009) Clinical evidence for a graft-versus-tumour effect following allogeneic HSCT for t(8;13) atypical myeloproliferative disorder. BONE MARROW TRANSPL , 44 (3) 197 - 199. 10.1038/bmt.2008.448.

Tulpule, S; Shaw, BE; Makoni, P; Little, AM; Madrigal, JA; Goldman, JM; (2009) Severe allergic reaction with anaphylaxis to G-CSF (lenograstim) in a healthy donor. BONE MARROW TRANSPL , 44 (2) 129 - 130. 10.1038/bmt.2008.438.

V

Velica, P; Davies, NJ; Rocha, PP; Schrewe, H; Ride, JP; Bunce, CM; (2009) Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers. MOL CANCER , 8 , Article 121. 10.1186/1476-4598-8-121. Gold open access

W

Ward, NJ; Apolonia, L; Cochrane, M; Buckley, SM; Waddington, SN; Nathwani, AC; Philpott, NJ; ... Thrasher, AJ; + view all (2009) Nonintegrating Lentiviral Vectors for Treatment of Haemophilia B. In: MOLECULAR THERAPY. (pp. S310 - S310). NATURE PUBLISHING GROUP

West, M; Nicholls, K; Mehta, A; Clarke, J; Steiner, R; Beck, M; Barshop, B; ... Mensah, RSR; + view all (2009) Clinical trial summary of agalsidase alfa in kidney dysfunction in Fabry disease. Journal of the American Society of Nephrology

West, M; Nicholls, K; Mehta, A; Clarke, JT; Steiner, R; Beck, M; Barshop, BA; ... Schiffman, R; + view all (2009) Agalsidase alfa and kidney dysfunction in Fabry disease. Journal of the American Society of Nephrology , 20 (5) pp. 1132-1139.

Widén, A; Rolando, N; Manousou, P; Rolles, K; Davidson, B; Sharma, D; Tuddenham, E; (2009) Anticoagulation after liver transplantation: a retrospective audit and case-control study. Blood Coagul Fibrinolysis , 20 (8) pp. 615-618. 10.1097/MBC.0b013e32832c87c8.

Wong, YNS; Jack, RH; Mak, V; Henrik, M; Davies, EA; (2009) The epidemiology and survival of extrapulmonary small cell carcinoma in South East England, 1970-2004. BMC Cancer , 9 209-. 10.1186/1471-2407-9-209.

Wu, P; Davies, FE; Boyd, K; Thomas, K; Dines, S; Saso, RM; Potter, MN; ... Morgan, GJ; + view all (2009) The impact of extramedullary disease at presentation on the outcome of myeloma. LEUKEMIA LYMPHOMA , 50 (2) 230 - 235. 10.1080/10428190802657751.

Z

Zimran, A; Morris, E; Mengel, E; Kaplan, P; Belmatoug, N; Hughes, DA; Malinova, V; ... vom Dahl, S; + view all (2009) The female Gaucher patient: The impact of enzyme replacement therapy around key reproductive events (menstruation, pregnancy and menopause). BLOOD CELLS MOLECULES AND DISEASES , 43 (3) pp. 264-288. 10.1016/j.bcmd.2009.04.003.

This list was generated on Sun Aug 18 05:05:11 2019 BST.